Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria

Enrolling by invitationOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

February 5, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2028

Conditions
Cystic FibrosisNontuberculous Mycobacterial Lung DiseaseNontuberculous Mycobacterium InfectionMycobacterium InfectionsMycobacterium; Pulmonary
Interventions
BIOLOGICAL

mycobacteriophage

mycobacteriophage phage that has been found effective in killing participants NTM infection

Trial Locations (18)

10032

Columbia University, New York

15213

University of Pittsburgh Medical Center, Pittsburgh

21218

John Hopkins University, Baltimore

27599

University of North Carolina at Chapel Hill, Chapel Hill

32610

University of Florida, Gainesville

35233

University of Alabama, Birmingham

43215

Nationwide Children's Hospital, Columbus

48109

University of Michigan, Ann Arbor

60611

Northwestern University, Chicago

75390

Southwestern Medical Center at Dallas, Dallas

80045

Childrens Hospital Colorado, Denver

80206

National Jewish Health, Denver

90027

Children's Hospital of Los Angeles, Los Angeles

92103

University of California, San Diego

98195

University of Washington, Seattle

02115

Boston Childrens Hospital, Boston

03756

Dartmouth Hitchcock Medical Center, Lebanon

05401

University of Vermont, Burlington

All Listed Sponsors
collaborator

Cystic Fibrosis Foundation

OTHER

lead

National Jewish Health

OTHER